Vext Science, Inc.
VEXTF
$0.2289
-$0.0061-2.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.45% | 14.89% | 3.40% | -1.04% | -2.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.45% | 14.89% | 3.40% | -1.04% | -2.40% |
| Cost of Revenue | 19.87% | 15.01% | 18.60% | 27.10% | 46.75% |
| Gross Profit | 75.38% | 14.56% | -25.33% | -39.92% | -54.44% |
| SG&A Expenses | -30.30% | -18.60% | -17.66% | 89.87% | 86.31% |
| Depreciation & Amortization | 11.07% | 28.07% | 44.61% | 60.79% | 85.45% |
| Other Operating Expenses | 4,787.14% | 2,623.85% | 2,068.42% | 94.44% | 41.67% |
| Total Operating Expenses | 3.18% | 7.75% | 11.41% | 48.19% | 63.39% |
| Operating Income | 56.44% | 12.68% | -46.82% | -2,294.34% | -538.45% |
| Income Before Tax | -114.86% | -702.65% | -728.12% | -33.19% | -528.79% |
| Income Tax Expenses | 323.62% | 708.25% | 226.79% | 116.79% | 109.38% |
| Earnings from Continuing Operations | -138.32% | -867.91% | -610.06% | -250.02% | -194.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.32% | -867.91% | -610.06% | -250.02% | -194.69% |
| EBIT | 56.44% | 12.68% | -46.82% | -2,294.34% | -538.45% |
| EBITDA | 310.01% | 592.31% | 90.50% | -122.14% | -133.65% |
| EPS Basic | -113.06% | -695.96% | -599.47% | -180.49% | -160.62% |
| Normalized Basic EPS | 36.18% | -1.35% | -37.79% | -239.72% | -54,000.00% |
| EPS Diluted | -100.90% | -567.80% | -609.63% | -185.71% | -164.41% |
| Normalized Diluted EPS | 36.25% | -1.35% | -37.90% | -238.30% | -53,900.00% |
| Average Basic Shares Outstanding | 19.12% | 34.37% | 46.41% | 56.84% | 43.40% |
| Average Diluted Shares Outstanding | 19.31% | 34.50% | 46.56% | 57.42% | 43.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |